Cannabidiol as a Treatment for Schizophrenia

IF 0.2 4区 医学 Q4 PSYCHIATRY Psychiatric Annals Pub Date : 2023-06-01 DOI:10.3928/00485713-20230505-01
João Roberto F. Lisboa, João Luís Simei, José Diogo R. de Souza, Felipe V. Gomes
{"title":"Cannabidiol as a Treatment for Schizophrenia","authors":"João Roberto F. Lisboa, João Luís Simei, José Diogo R. de Souza, Felipe V. Gomes","doi":"10.3928/00485713-20230505-01","DOIUrl":null,"url":null,"abstract":"Schizophrenia is a complex neuropsychiatric disorder that has undergone significant advancements in its treatment. However, there are still many aspects of symptom management and prevention that could benefit from new developments in psychopharmacology. One potential avenue is the use of cannabidiol (CBD), a major phytocannabinoid found in the cannabis plant. Preliminary evidence suggests that CBD could effectively treat certain symptoms of the disorder with fewer side effects than conventional antipsychotics. This article provides the reader with an in-depth discussion of the current scientific evidence concerning the use of CBD in the treatment of schizophrenia. [ Psychiatr Ann . 2023;53(6):252–255.]","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":"12 1","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatric Annals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3928/00485713-20230505-01","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Schizophrenia is a complex neuropsychiatric disorder that has undergone significant advancements in its treatment. However, there are still many aspects of symptom management and prevention that could benefit from new developments in psychopharmacology. One potential avenue is the use of cannabidiol (CBD), a major phytocannabinoid found in the cannabis plant. Preliminary evidence suggests that CBD could effectively treat certain symptoms of the disorder with fewer side effects than conventional antipsychotics. This article provides the reader with an in-depth discussion of the current scientific evidence concerning the use of CBD in the treatment of schizophrenia. [ Psychiatr Ann . 2023;53(6):252–255.]
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
大麻二酚治疗精神分裂症
精神分裂症是一种复杂的神经精神疾病,在治疗方面取得了重大进展。然而,仍有许多方面的症状管理和预防可以受益于精神药理学的新发展。一种潜在的途径是使用大麻二酚(CBD),大麻植物中发现的一种主要的植物大麻素。初步证据表明,与传统抗精神病药物相比,CBD可以有效治疗这种疾病的某些症状,而且副作用更少。这篇文章为读者提供了关于使用CBD治疗精神分裂症的当前科学证据的深入讨论。[精神病医生安。]2023; 53(6): 252 - 255。)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Psychiatric Annals
Psychiatric Annals PSYCHIATRY-
CiteScore
0.90
自引率
0.00%
发文量
77
期刊最新文献
Physician Coaching: An Intervention to Address the Burnout Gender Gap Among Physicians The Times, They Are a-Changing at Psychiatric Annals The Relationship Between Dyadic Coping Strategies and Posttraumatic Stress Symptoms in Pregnant Persons at Risk of Miscarriage A SAFER Workplace: Broadening Peer Support Programs Promoting Workforce Well-Being
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1